OrganiGram Holdings Inc.

OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. It focuses on producing cannabis for patients and adult recreational consumers. The firm's brands include Adult Recreational and Medical. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

OrganiGram Holdings, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company’s global footprint. Its brands include Edison, Big Bag O’ Buds, SHRED, Monjour, and Trailblazer. The company was founded on July 5, 2010 and is headquartered in Toronto, Canada.

OrganiGram (NASDAQ: OGI ) stock is rising higher on Monday after the cannabis company announced a new C$124.6 million investment. That investment comes from BT DE Investments Inc., which is a wholly-owned subsidiary of BAT (NYSE: BTI ).

Why Is OrganiGram (OGI) Stock Up 35% Today?

Organigram Holdings Inc has extended its relationship with British American Tobacco PLC (LSE:BATS) boosting its financial strength and positioning it to expand beyond Canada. The licensed producer of cannabis said BAT, the owner of Rothmans and Lucky Strike, is investing a further C$124.6 million in the business, building on an initial C$221 million injection back in 2021.

Organigram jumps after securing further investment from BAT

The stock of Canadian cannabis company Organigram Holdings Inc. OGI, +4.50% soared 10% premarket Monday, after the company said it is getting a C$124.6 million ($91.3 million) investment from British American Tobacco Plc BATS, -0.36%. The company will use C$83.1 million of the investment to crate “Jupiter,” a strategic investment pool targeting emerging growth opportunities to help Organigram expand its geographic footprint.

Organigram's stock soars premarket as it receives C$124.6 million investment from BAT

British American Tobacco

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce a C$124.6 million follow-on strategic equity investment from BT DE Investments Inc., (the “Investment”), a wholly-owned subsidiary of BAT (LSE: BATS and NYSE: BTI) (“BAT”), a leading, multi-category consumer goods business with a purpose to build A Better Tomorrow.™ “We are excited to bring this transformative transaction t.

Organigram Announces C$124.6 Million Investment from BAT and Creation of “Jupiter” Strategic Investment Pool

Aurora Cannabis

Cronos Group

The cannabis industry has continued to flourish even with all the happening in the sector. Just in the U.S. alone, there are over 30 legal states all generating close to or over a billion dollars in revenue. Yet there is still no type of federal reform in place. As some may know there was a recent attempt to pass cannabis banking legislation that has once again failed to pass. Nevertheless, legal cannabis businesses are still open and profiting in a major way. Companies are growing and making more money which on a state level is helping in many ways.

Marijuana Stock Alerts: 3 Canadian Cannabis Companies To Watch Today

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to provide a corporate update. Market Share Momentum Market share continues to be an important indicator of success for licensed producers (“LPs”) in Canada as sell through to consumers is a strong predictor of long-term sustainable revenue. Organigram is pleased to announce that it has moved into the #2 market share position in the la.

Organigram Provides Corporate Update

SNDL Inc.

Canopy Growth

HEXO Corp

Tilray Brands

Tuesday, October 17, 2023 marks five years since recreational cannabis was legalized in Canada and it's been tough going for operators in the budding sector. Industry players have had to contend with oversaturation, competition from the black market, limited opportunities to enter the United States market, and, more recently, challenging broader economic conditions due to high inflation and interest rates.

Cannabis stocks struggle as Canada marks five years of legal recreational use

I have been bullish on Organigram for quite some time, but it has dropped significantly. The stock is ridiculously cheap in my view. I expect that the stock can more than double over the next year.

Organigram Is A Great Stock For Value Investors

As we enter the fourth quarter of 2023, investors looking for possibilities in the rapidly growing global cannabis market continue to focus on Canadian marijuana stocks. The cannabis sector has expanded significantly in recent years as more and more nations legalize cannabis for recreational use, including Canada. According to Grand View Research, the worldwide cannabis market is predicted to reach $103.9 billion by 2024, poised for an accelerated expansion. Specifically, Canadian marijuana stocks continue to be in high demand in this developing industry, making it crucial for investors to use short-term trading tactics and technical analysis while keeping a close eye on risk management to maximize their gains.

Q4 Potential: Best Canadian Marijuana Stocks for Mid-October

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licenced producer of cannabis, announced today that it has obtained a receipt for a final short form base shelf prospectus (the “Base Shelf Prospectus”) filed with the securities commissions in each of the provinces and territories of Canada. A corresponding shelf registration statement on Form F-10 (the “Registration Statement”) has been filed with the United States Securitie.

Organigram Holdings Inc. Files Final Base Shelf Prospectus

Marijuana stock investors are keeping their eyes open for a chance to take profits. For some time the level of volatile trading has made it tough to do so. Although it has its pros and cons there has been a lack of upward trading. From this, it has left many more traders with concerns about future trading. Yet some see this as a means to prepare for the future as the cannabis industry is still developing. More companies are working to expand the industry and keep things moving in the right direction.

3 Marijuana Stocks To Buy In October 2023

Growing brands and strategic positioning show OGI's future potential. Having overcome recent challenges, OGI is positioned to thrive in the changing cannabis industry. The company's earnings estimates for 2024 are promising, and its strong balance sheet and strategic investments make it an attractive investment opportunity.

Organigram Holdings: Earnings Growth Set To Continue

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licenced producer of cannabis, announced today that it has filed a preliminary short form base shelf prospectus (the “Base Shelf Prospectus”) with the securities commissions in each of the provinces and territories of Canada. A corresponding shelf registration statement on Form F-10 (the “Registration Statement”) has been filed with the United States Securities and Exchange Co.

Organigram Holdings Inc. Files Preliminary Base Shelf Prospectus

Marijuana stock investors are keeping focused on the future of the cannabis industry. Right now even with an increase in volatile trading, the industry is still progressing. There are more states and global regions that are working to establish legal cannabis markets. It seems that the toughest hurdle to get passed is cannabis reform whether it's the state level or federal. Although federal reform is what some are calling the last true obstacle of the sector. Now for the US cannabis industry, this holds more truth than not.

Best Cannabis & Marijuana Stocks For Q3 2023

Curaleaf Holdings, Inc.

The House of Representatives is set to meet to discuss several pot-related measures this week. The march toward full U.S. legalization continues to gather pace.

Why Marijuana Stocks Triumphed on Monday

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

Cannabis stocks continued to move higher following the Labor Day long weekend after the U.S. Department of Health and Human Services (HHS) last week recommended reclassifying marijuana as a lower-risk drug.

Cannabis stock rally continues on marijuana rescheduling hopes

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announces today that Ms. Caroline Ferland has resigned from the Board of Directors (“the Board”) effective immediately. Ms. Ferland was a board member nominee appointed by BAT. “In her short time on the Board, Ms. Ferland made considerable contributions to Organigram,” said Peter Amirault, Chair of Organigram's Board of Directors. “In addition to.

Organigram Announces Resignation of Board Member

AdvisorShares Pure US Cannabis ETF

Shares of marijuana companies climbed as much as 14% in morning trading on Thursday after the Department of Health and Human Services recommended its reclassification as a lower-risk substance following an 11-month review.

Pot firms gain as US move to ease curbs boosts sentiment

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to launch its first range of whole-flower derived THCV products through the Company's popular SHRED and newly re-launched Trailblazer brands. Reaffirming its commitment to forward-looking innovation, Organigram strives to maintain a competitive advantage in the cannabis industry, most recently through its strategic investment in Phylos.

Organigram Launches First Range of THCV Products Derived from Moncton-Grown Whole Flower

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the relaunch of one of Canada's best known cannabis brands, Trailblazer, exemplifying the Company's commitment to keeping consumer insights at the heart of its brand and product development strategy. More than a year in the making, Trailblazer's modernized brand identity and revitalized product lineup represent a significan.

Organigram Relaunches one of Canada's First Cannabis Brands, Trailblazer

Innovative Industrial Properties

Despite the ongoing challenges, the cannabis industry has been responsive to innovation, growth, and transformation. The article lists three key players poised to capitalize on unique aspects of the cannabis market.

3 Cannabis Stocks to Snap Up Before They Skyrocket

High Tide

As Canada's cannabis sector grows, knowledgeable investors look for chances in marijuana penny stocks in 2023. These lower-priced stocks have the potential for quick gains, making them tempting to day traders and swing traders looking for quick profits. However, approaching this market with prudence and a strong plan that includes good risk management and technical analysis to understand the peculiar characteristics of penny stocks is critical.

Mid-August 2023 Watchlist: Promising Canadian Cannabis Penny Stocks for Traders

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce today that it has expanded its global footprint by entering into a supply agreement (“the Agreement”) to provide dried Medical Cannabis flower to 4C LABS, a rapidly scaling healthcare, technology, and pharmaceutical company focused on virtual prescribing, pharmaceutical distribution, and clinical development of cannabis-bas.

Organigram to Enter the United Kingdom with Agreement to Supply Medical Cannabis to 4C LABS

In August 2023, the Canadian cannabis sector and top marijuana stocks attracted the attention of many investors. The quarterly cannabis earnings season has begun, providing light on the financial performance and growth prospects of Canada's biggest cannabis companies. This critical juncture offers investors a unique chance to examine the industry's current picture and contemplate strategic holdings in leading Canadian cannabis stocks. With the cannabis industry quickly expanding, knowledgeable traders are navigating the subtleties of short- and long-term trading methods while utilizing technical analysis to maximize entry and exit points.

Top Canadian Cannabis Stocks To Watch In August 2023

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announced today that the Federal Court of Canada (the “Court”) has granted Organigram's application for judicial review of a decision of Health Canada determining that the Edison Jolts lozenges (the “Products”) are to be classified as edible cannabis. The Court found there was a breach of procedural fairness by Health Canada. The matter is being remitted back to Health Canada for redeterm.

News for OrganiGram Holdings Inc. Stock (OGI)